Ansell reports full year sales of US$2.14B

• Ansell reported a full-year sales increase to US$2.14 billion alongside an adjusted earnings per share of US$1.49.
• Following the announcement, the Ansell share price rose to $41.88.
• The company stated that sales growth was driven by strong momentum in strategic markets like the scientific vertical and the United States.

Ansell (ASX:ANN) reported full-year sales of US$2.14 billion for the period ended June 30, marking a 5% increase on an organic constant currency basis.

Sales growth was supported by strong momentum in strategic markets, including the scientific vertical, where Cleanroom sales grew 10% on an adjusted basis, and the US, where sales grew 10% on an adjusted basis.

Adjusted EBIT came to $321.9 million, representing growth of 14.9%.

“Our ability to deliver on our performance commitments while navigating these challenges – including taking the necessary actions to offset the effects of higher tariffs in the US and the Middle East crisis – speaks to the strength of our customer relationships, the significant customer value of our safety solutions, and the resilience of our supply chain,” stated Managing Director and CEO Nathalie Ahlström.

The company stated that EBIT margin expansion from increased sales in higher value end markets helped offset tariff effects and cost inflation.

The final dividend was 41.5 US cents per share. At a payout ratio of 50%, the full-year dividend was 68.1 cents per share.

Following the announcement, the Ansell share price was up at $41.88.

FY27 adjusted EPS is expected to be in the range of US$1.58 to US$1.70, up from US$1.49 in FY26.

The business operates across industrial and medical end markets, developing and distributing personal protective equipment globally.

Management has continued executing an on-market share buyback programme, with US$118.4 million completed out of a planned US$200 million allocation.